Font Size: a A A
Keyword [Epidermal growth factor receptor mutation]
Result: 1 - 20 | Page: 1 of 3
1. Epidermal Growth Factor Receptor Mutations In Patients With The Lung Cancer
2. Epidermal Growth Factor Receptor Gene Mutation And The Molecular Target Therapy Of Late Period Non-small-cell Lung Cancer
3. Detection Of EGFR Mutations In NSCLC Tumor Specimens From Various Ways By DHPLC And Comparison Of EGFR And K-ras Genotypes Between Primary Tumors And Corresponding Lymph Node Metastases In NSCLC
4. Analysis Of EGFR Mutation And Mutation Abundance In Prognosis Of Non - Small Cell Lung Cancer In Guangxi
5. Detection Of EGFR Mutations In Circulating DNA Of Lung Cancer Patients And Its Significance
6. Serum Proteomic Study On Epidermal Growth Factor Receptor Mutation Status In Patients With Advanced And Metastatic Non–Small-Cell Lung Cancer
7. Comparison Of EGFR Mutation Statuses In Paired Tissue And Plasma Samples In Non-small Cell Lung Cancer Patients
8. Epidermal Growth Factor Receptor Gene Mutation Status Is Associated With Clinical Characteristics, Chemotherapy Effect And The Outcome Of Non-small Cell Lung Cancer
9. Value Of The Epidermal Growth Factor Receptor Mutation Status For Predicting The Prognosis Of Non-Small-Cell Lung Cancer Patients
10. Study On The Significance Of The Expression And Mutation Of EGFR In Alveolar-epithelial Atypical Hyperplasia
11. Detection Of Epidermal Growth Factor Receptor Mutation In Esophageal Cancer And Gastric Cancer And The Study On Postoperative Adjuvant Treatment In Esophageal Cancer Patients
12. Immunocytochemstry Using Of Epidermal Growth Factor Receptor Mutation-specific Antibodies Of DelE746-A750and L858R In Lung Adenocarcinoma With Malignant Pleural Effusion
13. Detection And Clinical Significance Of Epidermal Growth Factor Receptor Mutation In Transbronchial Needle Aspiration Of Non-Small Cell Lung Cancer
14. Correlation Between EGFR Mutation Status And Response To First-line Platinum-based Chemotherapy In Patients With Advanced Non-small Cell Lung Cancer
15. Gefitinib-Integrated Regimen Versus Chemotherapy Alone In Advanced Pretreated Patients With Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma: A Case-Control Study
16. Circulating Plasma MicroRNAs As Potential Markers To Identify EGFR Mutation Status And To Monitor Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor Treatment In Patients With Advanced Non-small Cell Lung Cancer
17. The Correlation Between Serum Tumor Markers With EGFR Mutation And The Efficacy Treated By TKIs In Lung Adenocarcinoma
18. Relationship Between EGFR Mutations And Clinicopathological Features In NSCLC And Prognostic Analysis Of TKI Treatment
19. Clinical Evaluation Of An Improved Method For Epidermal Growth Factor Receptor Mutation Detection
20. Correlation Of Epidermal Growth Factor Receptor Mutations,Clinical Pathological Features And Prognosis In Patients With Lung Adenocarcinoma
  <<First  <Prev  Next>  Last>>  Jump to